Jounce Therapeutics DSO Ratio 2011-2026 | JNCE

Annual DSO Ratio Jounce Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	2.32	90.2	6.96	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
90.2	2.32	33.2

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	37.5	$ 22.56	2.13 %	$ 3.74 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.43	3.62 %	$ 368 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Alnylam Pharmaceuticals ALNY	58.1	$ 327.25	2.42 %	$ 42.9 B	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.9	3.7 %	$ 9.38 B	Australia
Autolus Therapeutics plc AUTL	58.2	$ 1.49	9.56 %	$ 397 M	Britain
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 20.4	-0.87 %	$ 954 M	USA
Aquestive Therapeutics AQST	103	$ 4.18	1.21 %	$ 447 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	150	$ 2.66	3.5 %	$ 16.7 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.61	5.76 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Celldex Therapeutics CLDX	321	$ 32.41	3.38 %	$ 2.15 B	USA
Celsion Corporation CLSN	15.6	-	-6.63 %	$ 13.9 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Chimerix CMRX	588	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA